SHARE CAPITAL (Tables)
|
12 Months Ended |
Mar. 31, 2026 |
|---|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
| Disclosure of share purchase warrants outstanding [Table Text Block] |
| |
|
Exercise |
|
|
Grant Date |
|
|
March 31, |
|
| |
|
Price |
|
|
Fair Value |
|
|
2026 |
|
| Expiry Date |
|
$ |
|
|
$ |
|
|
# |
|
| |
|
|
|
|
|
|
|
|
|
| August 19, 2026 |
|
3.00 |
|
|
89,737 |
|
|
1,180,750 |
|
| October 22, 2027 |
|
1.50 |
|
|
245,753 |
|
|
1,169,443 |
|
| April 9, 2028 |
|
2.20 |
|
|
42,393 |
|
|
908,000 |
|
| October 22, 2027 |
|
1.06 |
|
|
22,701 |
|
|
33,424 |
|
| October 22, 2028 |
|
2.00 |
|
|
242,092 |
|
|
1,169,443 |
|
| Less warrant value included in convertible debentures reserve |
|
|
|
|
(42,393 |
) |
|
- |
|
| |
|
|
|
|
600,283 |
|
|
4,461,060 |
|
|
| Disclosure of summary of warrants activity [Table Text Block] |
| |
|
Year ended |
|
|
Year ended |
|
| |
|
March 31, 2026 |
|
|
March 31, 2025 |
|
| |
|
|
|
|
Weighted |
|
|
|
|
|
Weighted |
|
| |
|
|
|
|
average |
|
|
|
|
|
average |
|
| |
|
Number |
|
|
exercise price |
|
|
Number |
|
|
exercise price |
|
| |
|
|
|
|
$ |
|
|
|
|
|
$ |
|
| Balance, beginning of year |
|
1,180,750 |
|
|
3.00 |
|
|
- |
|
|
- |
|
| Granted |
|
3,280,310 |
|
|
1.87 |
|
|
1,180,750 |
|
|
3.00 |
|
| Exercised |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
| Expired |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
| Balance, end of year |
|
4,461,060 |
|
|
2.17 |
|
|
1,180,750 |
|
|
3.00 |
|
|
| Disclosure of detailed information about options, valuation assumptions [Table Text Block] |
| |
Triera |
|
The Company |
| |
Mar 31, 2026 |
|
Mar 31, 2025 |
|
Mar 31, 2026 |
|
Mar 31, 2025 |
| Expected dividend yield |
N/A |
|
0% |
|
0% |
|
0% |
| Expected volatility |
N/A |
|
98% to 120% |
|
70% to 78% |
|
62% to 77% |
| Expected forfeiture rate |
N/A |
|
0% |
|
7% |
|
7% |
| Risk-free interest rate |
N/A |
|
4.50% |
|
2.4% to 2.7% |
|
4.0% to 4.5% |
| Expected life |
N/A |
|
3 years |
|
3 to 5 years |
|
3 to 5 years |
|
| Disclosure of share-based payment reserve [Table Text Block] |
| |
|
Year |
|
|
Year |
|
| |
|
Ended |
|
|
Ended |
|
| |
|
March 31, |
|
|
March 31, |
|
| |
|
2026 |
|
|
2025 |
|
| |
|
$ |
|
|
$ |
|
| |
|
|
|
|
|
|
| Share-based compensation expense |
|
786,963 |
|
|
1,529,934 |
|
|
| Disclosure of stock option and share-based payment activity [Table Text Block] |
| |
|
Year ended |
|
|
Year ended |
|
| |
|
March 31, 2026 |
|
|
March 31, 2025 |
|
| |
|
|
|
|
Weighted |
|
|
|
|
|
Weighted |
|
| |
|
|
|
|
average |
|
|
|
|
|
average |
|
| |
|
Number |
|
|
exercise price |
|
|
Number |
|
|
exercise price |
|
| |
|
|
|
|
$ |
|
|
|
|
|
$ |
|
| Balance, beginning of year |
|
6,123,334 |
|
|
2.32 |
|
|
7,098,334 |
|
|
2.37 |
|
| Granted |
|
1,579,000 |
|
|
1.06 |
|
|
2,000,000 |
|
|
1.52 |
|
| Exercised |
|
(642,834 |
) |
|
0.57 |
|
|
(1,700,000 |
) |
|
0.45 |
|
| Expired |
|
(1,452,833 |
) |
|
2.78 |
|
|
(1,275,000 |
) |
|
3.84 |
|
| Balance, end of year |
|
5,606,667 |
|
|
2.05 |
|
|
6,123,334 |
|
|
2.32 |
|
|
| Disclosure of outstanding options to acquire common shares [Table Text Block] |
| |
|
Options Outstanding |
|
|
Options Exercisable |
|
| |
|
|
|
|
Weighted |
|
|
Weighted |
|
|
|
|
|
Weighted |
|
| |
|
Number |
|
|
Average |
|
|
Average |
|
|
Number |
|
|
Average |
|
| |
|
Outstanding |
|
|
Remaining |
|
|
Exercise |
|
|
Outstanding |
|
|
Exercise |
|
| Range of exercise Prices |
|
as at Mar 31, |
|
|
Contractual |
|
|
Price |
|
|
as at Mar 31, |
|
|
Price |
|
| CAD$ |
|
2026 |
|
|
Life (years) |
|
|
CAD$ |
|
|
2026 |
|
|
CAD$ |
|
| $1.01 - $4.00 |
|
4,581,667 |
|
|
2.98 |
|
$ |
1.55 |
|
|
3,077,084 |
|
$ |
1.71 |
|
| $4.01 - $5.67 |
|
1,025,000 |
|
|
0.79 |
|
$ |
4.27 |
|
|
1,025,000 |
|
$ |
4.27 |
|
| Totals |
|
5,606,667 |
|
|
2.55 |
|
$ |
2.05 |
|
|
4,102,084 |
|
$ |
2.35 |
|
| |
|
Options Outstanding |
|
|
Options Exercisable |
|
| |
|
|
|
|
Weighted |
|
|
Weighted |
|
|
|
|
|
Weighted |
|
| |
|
Number |
|
|
Average |
|
|
Average |
|
|
Number |
|
|
Average |
|
| |
|
Outstanding |
|
|
Remaining |
|
|
Exercise |
|
|
Outstanding |
|
|
Exercise |
|
| Range of exercise Prices |
|
as at Mar 31, |
|
|
Contractual |
|
|
Price |
|
|
as at Mar 31, |
|
|
Price |
|
| CAD$ |
|
2025 |
|
|
Life (years) |
|
|
CAD$ |
|
|
2025 |
|
|
CAD$ |
|
| $0.40 - $1.00 |
|
633,334 |
|
|
0.28 |
|
$ |
0.55 |
|
|
633,334 |
|
$ |
0.55 |
|
| $1.01 - $4.00 |
|
4,465,000 |
|
|
2.75 |
|
$ |
2.12 |
|
|
3,135,416 |
|
$ |
2.37 |
|
| $4.01 - $5.67 |
|
1,025,000 |
|
|
1.79 |
|
$ |
4.27 |
|
|
1,025,000 |
|
$ |
4.27 |
|
| Totals |
|
6,123,334 |
|
|
2.33 |
|
$ |
2.32 |
|
|
4,793,750 |
|
$ |
2.54 |
|
|
| Triera Biosciences Ltd [Member] |
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
| Disclosure of stock option and share-based payment activity [Table Text Block] |
| |
|
Year ended |
|
|
Year ended |
|
| |
|
March 31, 2026 |
|
|
March 31, 2025 |
|
| |
|
|
|
|
Weighted |
|
|
|
|
|
Weighted |
|
| |
|
|
|
|
average |
|
|
|
|
|
average |
|
| |
|
Number |
|
|
exercise price |
|
|
Number |
|
|
exercise price |
|
| |
|
|
|
|
$ |
|
|
|
|
|
$ |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Balance, beginning of year |
|
190,000 |
|
|
1.00 |
|
|
195,000 |
|
|
1.00 |
|
| Granted |
|
- |
|
|
- |
|
|
5,000 |
|
|
1.00 |
|
| Exercised |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
| Expired |
|
- |
|
|
- |
|
|
(10,000 |
) |
|
1.00 |
|
| Balance, end of year |
|
190,000 |
|
|
1.00 |
|
|
190,000 |
|
|
1.00 |
|
|
| Disclosure of outstanding options to acquire common shares [Table Text Block] |
| |
|
Options Outstanding |
|
|
Options Exercisable |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
Weighted |
|
|
Weighted |
|
|
|
|
|
Weighted |
|
| |
|
Number |
|
|
Average |
|
|
Average |
|
|
Number |
|
|
Average |
|
| |
|
Outstanding |
|
|
Remaining |
|
|
Exercise |
|
|
Outstanding |
|
|
Exercise |
|
| Range of exercise Prices |
|
as at Mar 31, |
|
|
Contractual |
|
|
Price |
|
|
as at Mar 31, |
|
|
Price |
|
| CAD$ |
|
2026 |
|
|
Life (years) |
|
|
CAD$ |
|
|
2026 |
|
|
CAD$ |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| $0.00 - $1.00 |
|
190,000 |
|
|
2.30 |
|
$ |
1.00 |
|
|
188,333 |
|
$ |
1.00 |
|
| |
|
Options Outstanding |
|
|
Options Exercisable |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
Weighted |
|
|
Weighted |
|
|
|
|
|
Weighted |
|
| |
|
Number |
|
|
Average |
|
|
Average |
|
|
Number |
|
|
Average |
|
| |
|
Outstanding |
|
|
Remaining |
|
|
Exercise |
|
|
Outstanding |
|
|
Exercise |
|
| Range of exercise Prices |
|
as at Mar 31, |
|
|
Contractual |
|
|
Price |
|
|
as at Mar 31, |
|
|
Price |
|
| CAD$ |
|
2025 |
|
|
Life (years) |
|
|
CAD$ |
|
|
2025 |
|
|
CAD$ |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| $0.00 - $1.00 |
|
190,000 |
|
|
3.22 |
|
$ |
1.00 |
|
|
186,666 |
|
$ |
1.00 |
|
|